Breaking News

Syntegon Sells First Versynta microBatch to Vetter

Annex 1-compliant production cell with gloveless isolator and integrated air treatment is designed to offer new technological advances in aseptic filling.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Syntegon announced the first sale of its new Versynta microBatch to development partner Vetter. The Annex 1-compliant production cell with gloveless isolator and integrated air treatment is designed to offer new technological advances in aseptic filling. Syntegon launched the new Versynta microBatch at CPHI Barcelona this past October.    According to the company, the 100% in-process control provides high quality, while five integrated inline inspection systems ensure continuous process monito...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters